Teachers and Schools Across North America Receive $10,000 Amgen Award for Science Teaching Excellence
- Details
- Category: Amgen
Amgen (NASDAQ: AMGN) announced the 34 science teachers in the United States, Canada and Puerto Rico who are this year's recipients of the 19th annual Amgen Award for Science Teaching Excellence.
Boehringer Ingelheim and Ashoka announce a global partnership for "Making More Health"
- Details
- Category: Boehringer Ingelheim
Boehringer Ingelheim and Ashoka will launch a three-year global initiative to improve health in communities around the world.The "Making More Health" initiative will promote healthy individuals, families and communities by identifying and supporting the most promising solutions to challenge health problems.
Abbott and Biotest Announce Global Agreement to Develop and Commercialize Novel Antibody for Autoimmune Diseases
- Details
- Category: Abbott
Abbott and Biotest AG announced a global agreement to develop and commercialize BT-061, a novel anti-CD4 antibody for the treatment of rheumatoid arthritis (RA) and psoriasis.
FDA panel endorses efficacy but not safety of Novartis drug ACZ885 for gouty arthritis
- Details
- Category: Novartis
An advisory committee of the Food and Drug Administration (FDA) today voted in favor of the overall efficacy but not the overall safety of ACZ885 (canakinumab) to treat gouty arthritis attacks in patients who cannot obtain adequate relief with non-steroidal anti-inflammatory drugs (NSAIDs) or colchicine.
Pivotal study showed vismodegib helped shrink tumours or heal lesions
- Details
- Category: Roche
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that a pivotal Phase II study with vismodegib showed positive results in people with advanced basal cell carcinoma (BCC) for whom surgery is considered inappropriate.
Genzyme Celebrates 20th Anniversary of Gaucher Disease Registry with Launch of New Web Platform
- Details
- Category: Genzyme
Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced the launch of a new web-based platform, RegistryNXT!SM, to support the International Collaborative Gaucher Group (ICGG) Gaucher Registry.
Novartis begins construction of new state-of-the-art pharmaceutical manufacturing plant in St. Petersburg, Russia
- Details
- Category: Novartis
Novartis held a groundbreaking ceremony to announce the start of construction of a pharmaceutical manufacturing plant in St. Petersburg, Russia. The construction of this facility represents the most significant Novartis investment in Russia to date.
More Pharma News ...
- AstraZeneca extends its investment in Russia
- Nycomed to market Roche's osteoporosis treatment Bonviva in key Asia-Pacific markets
- GSK to purchase Shenzhen Neptunus stake in previously formed joint venture for influenza vaccines in China
- Synthes and Lilly Sign Development and Collaboration Agreement
- GlaxoSmithKline and Valeant announce US FDA approval of Potiga™ (ezogabine)
- Abbott Reports Interim Results From Phase III Open-Label Study of Investigational Treatment for Advanced Parkinson's Disease
- Millions of children in the world's poorest countries could receive vaccination against rotavirus diarrhoeal disease